• By Jennifer O'Hara

Mayo Clinic Q&A podcast: Cardiac risks of off-label drugs to treat COVID-19

April 8, 2020

A study published recently in Mayo Clinic Proceedings details information about potential cardiac side effects when using off-label drugs to treat COVID-19. Off-label means the drug has been approved by the Food and Drug Administration to treat a different condition. Some of the off-label drugs being used to treat COVID-19 have a risk of sudden cardiac arrest and death.

On the Mayo Clinic Q&A podcast, Dr. Michael Ackerman, a Mayo Clinic genetic cardiologist and director of the Windland Smith Rice Sudden Death Genomics Laboratory, explains how heart monitoring is important to identify at-risk patients.

Click the player below:

Mayo Clinic Q&A is available on podcast platforms including AppleGoogleSpotifyStitcherTuneIn and iHeart

_________________________________________________

For the latest updates on the COVID-19 pandemic, check the CDC website. For more information and COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.

Please login or register to post a reply.